Skip to menu Skip to content Skip to footer
Professor Carl Lavie
Professor

Carl Lavie

Email: 

Overview

Background

CARL (CHIP) LAVIE, JR., M.D., FACC, FACP, FCCP

Ochsner Clinical School – The University of Queensland School of Medicine, clavie@ochsner.org

Dr. Lavie graduated from Louisiana State University Medical School in 1983 and completed internal medicine residency at Ochsner and fellowship in cardiovascular diseases at Mayo , where he joined the faculty in 1989. Dr. Lavie is Professor of Medicine and Medical Director, Cardiac Rehabilitation and Preventive Cardiology; Director, Exercise Testing Laboratory; and Staff Cardiologist, Echocardiographic Laboratory at the John Ochsner Heart and Vascular Institute in New Orleans, Ochsner Clinical School-The University of Queensland School of Medicine and he previously served for 10 years as Associate Director of the Internal Medicine Training program. He served as a Consultant in the Department of Preventive Medicine at the Pennington Biomedical Research Center in Baton Rouge, Louisiana from January 2012-October 2014. Dr. Lavie’s research interests include cardiac rehabilitation and prevention, lipids, hypertension, obesity, and exercise, as well as noninvasive testing, encompassing echocardiography, exercise testing, and nuclear cardiology. He is the author of over 800 medical publications including two cardiology textbooks, and 40 book chapters. Dr. Lavie serves as a frequent lecturer, reviewer for several medical journals, and is Associate Editor and Cardiovascular Section Editor of the Mayo Clinic Proceedings and is Editor in Chief of Progress in Cardiovascular Diseases and serves on the Editorial Boards of the Journal of the American College of Cardiology, American Journal of Cardiology, Journal of Cardiopulmonary Rehabilitation Prevention, and over 20 other Journals.For 2011 till now, he has served as Chairman of the Document Oversights Committee for AACVPR. For the years 2003 and 2004 he served as Chairman of Vascular, Hypertension and Prevention for the American College of Cardiology and he has been an elite reviewer for JACC for 7 of the last 8 years, also receiving the Simon Dack Award as a life-time, hall of fame, reviewer.In 2013, he gave Key-Note lectures for both the American College of Sports Medicine and the Cardiac Rehabilitation one for the AACVPR, where he received the 2013 Research Award. From a personal stand-point, he is an avid sports fan and competitive runner, with personal records in the 5K, 10K, Half-Marathon and Marathon of 18:30,38:30,1:24:30, and 3:10, respectively. He is the author of “The Obesity Paradox” ,released April,2014.John Ochsner Heart and Vascular Institute

1514 Jefferson Highway, New Orleans, LA 70121

Telephone: (504) 842-1281 or 842-5874, FAX: (504) 842-5875

E-mail: clavie@ochsner.org

Admin. Asst. (Jean Ann Landry): jlandry@ochsner.org

Availability

Professor Carl Lavie is:
Available for supervision
Media expert

Works

Search Professor Carl Lavie’s works on UQ eSpace

1208 works between 1984 and 2025

321 - 340 of 1208 works

2020

Journal Article

Weathering the cytokine storm in COVID-19: therapeutic implications

Iannaccone, Giulia, Scacciavillani, Roberto, Del Buono, Marco Giuseppe, Camilli, Massimiliano, Ronco, Claudio, Lavie, Carl J., Abbate, Antonio, Crea, Filippo, Massetti, Massimo and Aspromonte, Nadia (2020). Weathering the cytokine storm in COVID-19: therapeutic implications. CardioRenal Medicine, 10 (5), 277-287. doi: 10.1159/000509483

Weathering the cytokine storm in COVID-19: therapeutic implications

2020

Journal Article

Laparoscopic Sleeve Gastrectomy in Patients with Obesity and Ventricular Assist Devices: a Comprehensive Outcome Analysis

daSilva-deAbreu, Adrian, Garikapati, Kiran, Alhafez, Bader Aldeen, Desai, Sapna, Eiswirth, Clement, Krim, Selim, Patel, Hamang, Ventura, Hector O., Lavie, Carl J., Francisco Loro-Ferrer, Juan and Mandras, Stacy A. (2020). Laparoscopic Sleeve Gastrectomy in Patients with Obesity and Ventricular Assist Devices: a Comprehensive Outcome Analysis. Obesity Surgery, 31 (2), 884-890. doi: 10.1007/s11695-020-04948-9

Laparoscopic Sleeve Gastrectomy in Patients with Obesity and Ventricular Assist Devices: a Comprehensive Outcome Analysis

2020

Journal Article

Cardiovascular Effects of ADHD Therapies: JACC Review Topic of the Week

Torres-Acosta, Noel, O'Keefe, James H., O'Keefe, Caroline L. and Lavie, Carl J. (2020). Cardiovascular Effects of ADHD Therapies: JACC Review Topic of the Week. Journal of the American College of Cardiology, 76 (7), 858-866. doi: 10.1016/j.jacc.2020.05.081

Cardiovascular Effects of ADHD Therapies: JACC Review Topic of the Week

2020

Journal Article

Management of Thrombotic Complications in COVID-19: An Update

Hajra, Adrija, Mathai, Sheetal Vasundara, Ball, Somedeb, Bandyopadhyay, Dhrubajyoti, Veyseh, Maedeh, Chakraborty, Sandipan, Lavie, Carl J. and Aronow, Wilbert S. (2020). Management of Thrombotic Complications in COVID-19: An Update. Drugs, 80 (15), 1553-1562. doi: 10.1007/s40265-020-01377-x

Management of Thrombotic Complications in COVID-19: An Update

2020

Journal Article

Bariatric surgery in obese patients with ventricular assist devices

daSilva-deAbreu, Adrian, Alhafez, Bader Aldeen, Curbelo-Pena, Yuhamy, Lavie, Carl J., Ventura, Hector O., Loro-Ferrer, Juan Francisco and Mandras, Stacy A. (2020). Bariatric surgery in obese patients with ventricular assist devices. BMC Research Notes, 13 (1) 382, 382. doi: 10.1186/s13104-020-05221-z

Bariatric surgery in obese patients with ventricular assist devices

2020

Journal Article

Famotidine Against SARS-CoV2: A Hope or Hype?

Ghosh, Ritwik, Chatterjee, Subhankar, Dubey, Souvik and Lavie, Carl J. (2020). Famotidine Against SARS-CoV2: A Hope or Hype?. Mayo Clinic Proceedings, 95 (8), 1797-1799. doi: 10.1016/j.mayocp.2020.05.027

Famotidine Against SARS-CoV2: A Hope or Hype?

2020

Journal Article

Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?

Lippi, Giuseppe, Lavie, Carl J., Henry, Brandon M. and Sanchis-Gomar, Fabian (2020). Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?. Clinical Chemistry and Laboratory Medicine, 58 (9), 1415-1422. doi: 10.1515/cclm-2020-0727

Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?

2020

Journal Article

Impact of obesity on adverse in-hospital outcomes in patients undergoing percutaneous mitral valve edge-to-edge repair using MitraClip® procedure - Results from the German nationwide inpatient sample

Keller, Karsten, Hobohm, Lukas, Geyer, Martin, Kreidel, Felix, Ostad, Mir A., Lavie, Carl J., Lankeit, Mareike, Konstantinides, Stavros, Münzel, Thomas and von Bardeleben, Ralph Stephan (2020). Impact of obesity on adverse in-hospital outcomes in patients undergoing percutaneous mitral valve edge-to-edge repair using MitraClip® procedure - Results from the German nationwide inpatient sample. Nutrition, Metabolism and Cardiovascular Diseases, 30 (8), 1365-1374. doi: 10.1016/j.numecd.2020.04.009

Impact of obesity on adverse in-hospital outcomes in patients undergoing percutaneous mitral valve edge-to-edge repair using MitraClip® procedure - Results from the German nationwide inpatient sample

2020

Journal Article

Pharmaco-immunomodulatory therapy in COVID-19

Rizk, John G., Kalantar-Zadeh, Kamyar, Mehra, Mandeep R., Lavie, Carl J., Rizk, Youssef and Forthal, Donald N. (2020). Pharmaco-immunomodulatory therapy in COVID-19. Drugs, 80 (13), 1267-1292. doi: 10.1007/s40265-020-01367-z

Pharmaco-immunomodulatory therapy in COVID-19

2020

Journal Article

Editorial: Hypertension in special populations and the role in comoborbities

Ventura, Hector O. and Lavie, Carl J. (2020). Editorial: Hypertension in special populations and the role in comoborbities. Current Opinion in Cardiology, 35 (4), 341-341. doi: 10.1097/HCO.0000000000000747

Editorial: Hypertension in special populations and the role in comoborbities

2020

Journal Article

The Journal of Cardiopulmonary Rehabilitation and Prevention at 40 yr and its role in promoting preventive cardiology: part 2

Franklin, Barry A., Brubaker, Peter, Harber, Matthew P., Lavie, Carl J., Myers, Jonathan and Kaminsky, Leonard A. (2020). The Journal of Cardiopulmonary Rehabilitation and Prevention at 40 yr and its role in promoting preventive cardiology: part 2. Journal of Cardiopulmonary Rehabilitation and Prevention, 40 (4), 209-214. doi: 10.1097/HCR.0000000000000523

The Journal of Cardiopulmonary Rehabilitation and Prevention at 40 yr and its role in promoting preventive cardiology: part 2

2020

Journal Article

In reply—Angiotensin-converting enzyme 2 and the resolution of inflammation: In support of continuation of prescribed angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

Sanchis-Gomar, Fabian, Lavie, Carl J., Perez-Quilis, Carme, Henry, Brandon M. and Lippi, Giuseppe (2020). In reply—Angiotensin-converting enzyme 2 and the resolution of inflammation: In support of continuation of prescribed angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Mayo Clinic Proceedings, 95 (7), 1553-1556. doi: 10.1016/j.mayocp.2020.05.003

In reply—Angiotensin-converting enzyme 2 and the resolution of inflammation: In support of continuation of prescribed angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

2020

Journal Article

Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients?

Sanchis-Gomar, Fabian, Perez-Quilis, Carme and Lavie, Carl J. (2020). Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients?. European Heart Journal, 41 (32), 3092-3093. doi: 10.1093/eurheartj/ehaa509

Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients?

2020

Journal Article

Hypertension in obesity

Mendoza, Michael F., Kachur, Sergey M. and Lavie, Carl J. (2020). Hypertension in obesity. Current Opinion in Cardiology, 35 (4), 389-396. doi: 10.1097/HCO.0000000000000749

Hypertension in obesity

2020

Journal Article

Obesity and outcomes in COVID-19: when an epidemic and pandemic collide

Sanchis-Gomar, Fabian, Lavie, Carl J., Mehra, Mandeep R., Henry, Brandon Michael and Lippi, Giuseppe (2020). Obesity and outcomes in COVID-19: when an epidemic and pandemic collide. Mayo Clinic Proceedings, 95 (7), 1445-1453. doi: 10.1016/j.mayocp.2020.05.006

Obesity and outcomes in COVID-19: when an epidemic and pandemic collide

2020

Journal Article

SGLT2 inhibition, visceral adiposity, weight, and type 2 diabetes mellitus

Carbone, Salvatore, O'Keefe, James H. and Lavie, Carl J. (2020). SGLT2 inhibition, visceral adiposity, weight, and type 2 diabetes mellitus. Obesity, 28 (7), 1173-1173. doi: 10.1002/oby.22864

SGLT2 inhibition, visceral adiposity, weight, and type 2 diabetes mellitus

2020

Journal Article

Statistics 2020 at progress in cardiovascular diseases

Lavie, Carl J. (2020). Statistics 2020 at progress in cardiovascular diseases. Progress in Cardiovascular Diseases, 63 (4), 534-535. doi: 10.1016/j.pcad.2020.07.008

Statistics 2020 at progress in cardiovascular diseases

2020

Journal Article

Personal activity intelligence and mortality – Data from the Aerobics Center Longitudinal Study

Nauman, Javaid, Sui, Xuemei, Lavie, Carl J., Wen, Chi Pang, Laukkanen, Jari A., Blair, Steven N., Dunn, Patrick, Arena, Ross and Wisløff, Ulrik (2020). Personal activity intelligence and mortality – Data from the Aerobics Center Longitudinal Study. Progress in Cardiovascular Diseases, 64, 121-126. doi: 10.1016/j.pcad.2020.05.005

Personal activity intelligence and mortality – Data from the Aerobics Center Longitudinal Study

2020

Journal Article

Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States

Aggarwal, Saurabh, Garcia-Telles, Nelson, Aggarwal, Gaurav, Lavie, Carl, Lippi, Giuseppe and Henry, Brandon Michael (2020). Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States. Diagnosis, 7 (2), 91-96. doi: 10.1515/dx-2020-0046

Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States

2020

Journal Article

Angiotensin-converting enzyme 2 and antihypertensives (angiotensin receptor blockers and angiotensin-converting enzyme inhibitors) in coronavirus disease 2019

Sanchis-Gomar, Fabian, Lavie, Carl J., Perez-Quilis, Carme, Henry, Brandon M. and Lippi, Giuseppe (2020). Angiotensin-converting enzyme 2 and antihypertensives (angiotensin receptor blockers and angiotensin-converting enzyme inhibitors) in coronavirus disease 2019. Mayo Clinic Proceedings, 95 (6), 1222-1230. doi: 10.1016/j.mayocp.2020.03.026

Angiotensin-converting enzyme 2 and antihypertensives (angiotensin receptor blockers and angiotensin-converting enzyme inhibitors) in coronavirus disease 2019

Supervision

Availability

Professor Carl Lavie is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

Contact Professor Carl Lavie directly for media enquiries about their areas of expertise.

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au